In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
no speaker photo
Speaker
Associate Professor Jan Beyer-Westendorf
Jan Beyer-Westendorf Jan Beyer-Westendorf

University Hospital Dresden, Dresden (Germany)

10 presentations from this speaker

Beyond real word evidence: learnings from databases and registers

Event : ESC Congress 2019

  • Session : NOACs in cancer associated thrombosis: managing anticoagulation in cancer patients in clinical practice
  • Speaker : J Beyer-Westendorf (Dresden,DE)
  • Sponsored by Bayer AG

Thrombotic events in bleeding patients treated with andexanet alfa: an ANNEXA-4 sub-study

Event : ESC Congress 2019

  • Session : Interventions for stroke: From prevention to acute treatment
  • Speaker : J Beyer-Westendorf (Dresden,DE)

What do the data say about stroke prevention and renal impairment?

Event : ESC Congress 2018

  • Session : Translating real world evidence into your clinical practice for your multi-morbid patient
  • Speaker : J Beyer-Westendorf (Dresden,DE), R Kreutz (Berlin,DE), C Coleman (Suffield,US)
  • Sponsored by Bayer AG

Evaluating the prospective RWE registries... The rules.

Event : ESC Congress 2017

  • Session : From clinical theory to clinical practice... Phase lll studies of the novel oral anticoagulants (NOACs) to real world evidence (RWE)
  • Speaker : J Beyer-Westendorf (Dresden,DE)
  • Sponsored by Bayer AG

From study to the clinic... Does consistency of outcome matter.

Event : ESC Congress 2017

  • Session : The novel oral anticoagulants (NOACS)... From clinical theory to clinical practice - The value of consistency of outcome
  • Speaker : J Beyer-Westendorf (Dresden,DE), AJ Camm (London,GB), M Patel (Durham,US), C Coleman (Suffield,US)
  • Sponsored by Bayer AG

Making sense of the data.

Event : ESC Congress 2017

  • Session : From clinical theory to clinical practice... Phase lll studies of the novel oral anticoagulants (NOACs) to real world evidence (RWE)
  • Speaker : AJ Camm (London,GB), C Coleman (Suffield,US), J Beyer-Westendorf (Dresden,DE), M Patel (Durham,US)
  • Sponsored by Bayer AG

Periinterventional management of novel oral anticoagulants: results of the prospective Dresden NOAC registry

Event : ESC Congress 2013

  • Session : Intervention/ Peripheral circulation
  • Speaker : J Beyer-Westendorf (Dresden,DE)

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are